We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · October 26, 2020

Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy

Journal of Immunotherapy (Hagerstown, Md. : 1997)

 

Additional Info

Journal of Immunotherapy (Hagerstown, Md. : 1997)
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-Center Retrospective Analysis
J. Immunother. 2020 Oct 01;43(8)250-255, F Comito, I Leslie, L Boos, A Furness, L Pickering, S Turajlic, J Larkin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading